Reviva Pharmaceuticals Holdings Inc. (RVPH NASDAQ) stock market data APIs
$0.2871
-0.03(-10.4%)
as of February 6, 2026
Try our APIs with
free plan!
Reviva Pharmaceuticals Holdings Inc. Financial Data Overview
Price chart is built with
Anychart
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
Prev. Close
0.2871
Open
0.2616
High
0.3094
Low
0.258
52 wk Range
0.25-2.14
Market Cap
33 478 K
Shares Outstanding
117 M
EPS
-0.06
Beta
0.044
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Reviva Pharmaceuticals Holdings Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Reviva Pharmaceuticals Holdings Inc. data using free add-ons & libraries
Get Reviva Pharmaceuticals Holdings Inc. Fundamental Data
Reviva Pharmaceuticals Holdings Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -10 103 922
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: -0.1
Get Reviva Pharmaceuticals Holdings Inc. End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Reviva Pharmaceuticals Holdings Inc. News
New
Reviva Pharmaceuticals Holdings (RVPH) Records 37% Gain So far in 2026
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) is one of the stocks under $1 that will explode.Reviva Pharmaceuticals Holdings (RVPH) Records 37% in 2026 So far As of the market open on January ...
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
CUPERTINO, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapie...
Reviva Says FDA Recommended Second Phase 3 Trial For Brilaroxazine In Schizophrenia
(RTTNews) - Reviva Pharmaceuticals Holdings, Inc. (RVPH) announced that the U.S. FDA has recommended the initiation of a second Phase 3 trial RECOVER-2 for Brilaroxazine before submitting a New Drug A...
Biotech Momentum Builds In After-Hours Trading As BioAtla, Entero, And Sonnet Climb
(RTTNews) - Several small-cap biotech and healthcare stocks posted notable gains in after-hours trading on Friday, November 28, 2025, despite limited fresh news flow. Below is a roundup of the key mov...
Get Reviva Pharmaceuticals Holdings Inc. fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
